Axonius Unified Device Observability vs CyberOwl Medulla: Side-by-Side Comparison (2026)

Axonius Unified Device Observability: Asset visibility & risk mgmt platform for healthcare medical & IT devices. built by Axonius. Core capabilities include Medical device discovery and classification with 150+ attributes per asset, Support for medical protocols including HL7, DICOM, RTLS, and MDS2, Fleet-level risk scoring with FDA and MDS2 data integration..

CyberOwl Medulla: Maritime cybersecurity monitoring for vessel fleet visibility & IMO2021 compliance. built by CyberOwl. Core capabilities include Vessel system visibility, Cybersecurity monitoring of fleet systems, IMO 2021 compliance support..

Both serve the Medical Device Security market but differ in approach, feature depth, and target audience.

Axonius Unified Device Observability differentiates with Medical device discovery and classification with 150+ attributes per asset, Support for medical protocols including HL7, DICOM, RTLS, and MDS2, Fleet-level risk scoring with FDA and MDS2 data integration. CyberOwl Medulla differentiates with Vessel system visibility, Cybersecurity monitoring of fleet systems, IMO 2021 compliance support.

Axonius Unified Device Observability is developed by Axonius. CyberOwl Medulla is developed by CyberOwl. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

Axonius Unified Device Observability and CyberOwl Medulla serve similar Medical Device Security use cases: both cover Network Visibility. Review the feature comparison above to determine which fits your requirements.